Showing results (141-150 of 162) with videos related to
Sort By:
Pageof 17
Open Forum Infectious Diseases|April 1, 2024
Evolving AIDS- and non-AIDS Mortality and Predictors in the PISCIS Cohort of People Living With HIV in Catalonia and the Balearic Islands (Spain), 1998-2020Daniel K Nomah, Suju Jamarkattel, Andreu Bruguera, et al.The Lancet Regional Health. Europe|May 28, 2026
Incidence and Clinical, Virological, and Resistance Characteristics of HIV Infections Among pre-Exposure Prophylaxis Users in Spain (SCOPE Study): A Multicentre Prospective and Retrospective Cohort StudyMar Vera, Patricia Álvarez-López, Haridian Tato, et al.Open Forum Infectious Diseases|November 30, 2023
Virologic Response to Dolutegravir Plus Lamivudine in People With Suppressed Human Immunodeficiency Virus Type 1 and Historical M184V/I: A Systematic Literature Review and Meta-analysisMadhusudan Kabra, Tristan J Barber, Clotilde Allavena, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|April 25, 2009
Efficacy and safety of switching from boosted lopinavir to boosted atazanavir in patients with virological suppression receiving a LPV/r-containing HAART: the ATAZIP studyJosep Mallolas, Daniel Podzamczer, Ana Milinkovic, et al.AIDS (London, England)|February 18, 2015
Impact of low-level viremia on clinical and virological outcomes in treated HIV-1-infected patients, Marie-Anne Vandenhende, Suzanne Ingle, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|February 14, 2009
Safety of Switching Nevirapine Twice Daily to Nevirapine Once Daily in Virologically Suppressed PatientsDaniel Podzamczer, Montserrat Olmo, Jose Sanz, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|November 16, 2006
Less lipoatrophy and better lipid profile with abacavir as compared to stavudine: 96-week results of a randomized studyDaniel Podzamczer, Elena Ferrer, Pochita Sanchez, et al.The Lancet. HIV|June 11, 2026
Guidance on the clinical management of HIV-1 persistent low-level viraemia on antiretroviral treatment: a scoping review and an international Delphi consensusTommaso Clemente, Arjen J Stam, Olof Elvstam, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|August 14, 2024
Risk of tuberculosis after initiation of antiretroviral therapy among persons with HIV in EuropeIsik S Johansen, Ashley Roen, Christian Kraef, et al.AIDS (London, England)|December 11, 2023
Heavy antiretroviral exposure and exhausted/limited antiretroviral options: predictors and clinical outcomesAmanda Mocroft, Annegret Pelchen-Matthews, Jennifer Hoy, et al.Pageof 17